UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

Modeling neurodegeneration in Caenorhabditis elegans

Disease models & mechanisms, 2020-10, Vol.13 (10)

2020

Link zum Volltext

Verfügbarkeit prüfen

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

Cell, 2011-07, Vol.146 (1), p.37-52

2011

Link zum Volltext

Verfügbarkeit prüfen

Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events

Cell, 2014-01, Vol.156 (1-2), p.170-182

2014

Link zum Volltext

Verfügbarkeit prüfen

Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model

Disease models & mechanisms, 2023-06, Vol.16 (6)

Caldwell, Guy A

2023

Link zum Volltext

Verfügbarkeit prüfen

From bugs to bedside: functional annotation of human genetic variation for neurological disorders using invertebrate models

Human molecular genetics, 2022-10, Vol.31 (R1), p.R37-R46

2022

Link zum Volltext

Verfügbarkeit prüfen

Lysosomal impairment in Parkinson's disease

Movement disorders, 2013-06, Vol.28 (6), p.725-732

2013

Link zum Volltext

Verfügbarkeit prüfen

Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (11), p.4013-4018

2014

Link zum Volltext

Verfügbarkeit prüfen

Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in C. elegans Models of Parkinson's Disease

The Journal of neuroscience, 2017-11, Vol.37 (46), p.11085-11100

2017

Link zum Volltext

Verfügbarkeit prüfen

C. elegans as a model system to accelerate discovery for Parkinson disease

Current opinion in genetics & development, 2017-06, Vol.44, p.102-109

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans

PLoS genetics, 2022-08, Vol.18 (8), p.e1010115

2022

Link zum Volltext

Verfügbarkeit prüfen

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

Nature neuroscience, 2017-11, Vol.20 (11), p.1560

2017

Link zum Volltext

Verfügbarkeit prüfen

Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration

Human molecular genetics, 2018-12, Vol.27 (24), p.4176-4193

2018

Link zum Volltext

Verfügbarkeit prüfen

The Glycolytic Enzyme, GPI, Is a Functionally Conserved Modifier of Dopaminergic Neurodegeneration in Parkinson’s Models

Cell metabolism, 2014-07, Vol.20 (1), p.145-157

2014

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (38), p.E3976-E3985

2014

Link zum Volltext

Verfügbarkeit prüfen

Calcineurin determines toxic versus beneficial responses to α-synuclein

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (34), p.E3544-E3552

2014

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (1), p.145-150

2008

Link zum Volltext

Verfügbarkeit prüfen

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6161), p.979-983

2013

Link zum Volltext

Verfügbarkeit prüfen

Hypothesis-Based RNAi Screening Identifies Neuroprotective Genes in a Parkinson's Disease Model

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (2), p.728-733

2008

Link zum Volltext

Verfügbarkeit prüfen

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson's Disease

Brain sciences, 2019-03, Vol.9 (4), p.73

2019

Link zum Volltext

Verfügbarkeit prüfen

NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease

Human molecular genetics, 2017-10, Vol.26 (19), p.3823-3836

2017

Link zum Volltext

Verfügbarkeit prüfen

RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway

The Journal of neuroscience, 2014-11, Vol.34 (48), p.16076-16085

2014

Link zum Volltext

Verfügbarkeit prüfen

α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

Nature genetics, 2009-03, Vol.41 (3), p.308-315

2009

Link zum Volltext

Verfügbarkeit prüfen

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

Molecular brain, 2008-11, Vol.1 (1), p.17-17, Article 17

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models

Human molecular genetics, 2011-10, Vol.20 (20), p.3933-3942

2011

Link zum Volltext

Verfügbarkeit prüfen

Genetic and Pharmacological Discovery for Alzheimer’s Disease Using Caenorhabditis elegans

ACS chemical neuroscience, 2017-12, Vol.8 (12), p.2596-2606

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(215)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(100)
Animals
(86)
Humans
(68)
Caenorhabditis Elegans
(48)
Disease Models, Animal
(36)
Caenorhabditis Elegans - Genetics
(32)
Biochemistry & Molecular Biology
(30)
Parkinson's Disease
(30)
Alpha-Synuclein - Metabolism
(26)
Proteins
(26)
Neurons
(25)
Cell Biology
(24)
Neurodegeneration
(24)
Animals, Genetically Modified
(23)
Caenorhabditis Elegans - Metabolism
(23)
Neurosciences
(23)
Mutation
(22)
Neurosciences & Neurology
(22)
Biological And Medical Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modeling neurodegeneration in Caenorhabditis elegans

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events

Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model

From bugs to bedside: functional annotation of human genetic variation for neurological disorders using invertebrate models

Lysosomal impairment in Parkinson's disease

Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity

Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in C. elegans Models of Parkinson's Disease

C. elegans as a model system to accelerate discovery for Parkinson disease

Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration

The Glycolytic Enzyme, GPI, Is a Functionally Conserved Modifier of Dopaminergic Neurodegeneration in Parkinson’s Models

Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease

Calcineurin determines toxic versus beneficial responses to α-synuclein

Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Hypothesis-Based RNAi Screening Identifies Neuroprotective Genes in a Parkinson's Disease Model

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson's Disease

NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease

RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway

α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models

Genetic and Pharmacological Discovery for Alzheimer’s Disease Using Caenorhabditis elegans

Suchergebnisse filtern